Form 4 for TTRX Turn Therapeutics Inc.
Accepted 2025-10-29 00:00:00 ET · period of report 2025-10-23 · accession 0001104659-25-103894 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-10-29 | 2025-10-23 | TTRX | Chesed Abraham | Board Observer | P - Purchase | $4.60 | +14.3K | 1.45M | +1.0% | +$65.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-23 | P | A | 14,286 | $4.60 | 1,447,268 | I By ANC Merchant FLP and ANC Carlson FLP | — | — | (F1) Shares are held indirectly through ANC Merchant FLP and ANC Carlson FLP, each owned 48% by the reporting person, 48% by the reporting person's spouse, and 2% by each of the reporting person's two children; the reporting person disclaims beneficial ownership of the shares attributable to his spouse except to the extent of his pecuniary interest therein. |